Proposed Rule2023-28964
Controlled Substance Destruction Alternatives to Incineration; Extension of Comment Period
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
January 3, 2024
Issuing agencies
Justice DepartmentDrug Enforcement Administration
Abstract
The Drug Enforcement Administration (DEA) published an advance notice of proposed rulemaking entitled "Controlled Substance Destruction Alternatives to Incineration" in the Federal Register on October 31, 2023. DEA is extending the comment period on that advance notice until April 1, 2024.
Full Text
<html>
<head>
<title>Federal Register, Volume 89 Issue 2 (Wednesday, January 3, 2024)</title>
</head>
<body><pre>
[Federal Register Volume 89, Number 2 (Wednesday, January 3, 2024)]
[Proposed Rules]
[Page 308]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2023-28964]
[[Page 308]]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
21 CFR Part 1301
[Docket No. DEA-1144]
RIN 1117-AB84
Controlled Substance Destruction Alternatives to Incineration;
Extension of Comment Period
AGENCY: Drug Enforcement Administration, Department of Justice.
ACTION: Advance notice of proposed rulemaking; extension of comment
period.
-----------------------------------------------------------------------
SUMMARY: The Drug Enforcement Administration (DEA) published an advance
notice of proposed rulemaking entitled ``Controlled Substance
Destruction Alternatives to Incineration'' in the Federal Register on
October 31, 2023. DEA is extending the comment period on that advance
notice until April 1, 2024.
DATES: The comment period for the advanced notice of proposed
rulemaking published October 31, 2023, at 88 FR 74379 is extended until
April 1, 2024. Electronic comments must be submitted, and written
comments must be postmarked, on or before April 1, 2024. Commenters
should be aware that the electronic Federal Docket Management System
will not accept comments after 11:59 p.m. Eastern Time on the last day
of the comment period.
ADDRESSES: To ensure proper handling of comments, please reference
``RIN 1117-AB84/Docket No. DEA-1144'' on all correspondence, including
any attachments.
<bullet> Electronic comments: DEA encourages that all comments be
submitted electronically through the Federal eRulemaking Portal, which
provides the ability to type comments directly into the comment field
on the web page or to attach a file containing comments. Please go to
<a href="http://www.regulations.gov">http://www.regulations.gov</a> and follow the online instructions at that
site for submitting comments. Upon completion of your submission, you
will receive a Comment Tracking Number for your comment generated by
<a href="http://www.regulations.gov">http://www.regulations.gov</a>. Please be aware that submitted comments are
not instantaneously available for public view on <a href="http://www.regulations.gov">http://www.regulations.gov</a>. If you have received a Comment Tracking Number,
your comment has been successfully submitted, and there is no need to
resubmit the same comment.
<bullet> Paper comments: Paper comments that duplicate the
electronic submission are discouraged. Should you wish to mail a paper
comment in lieu of submitting a comment electronically, it should be
sent via regular or express mail to: Drug Enforcement Administration,
Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive,
Springfield, Virginia 22152. Hand-delivered comments will not be
accepted.
FOR FURTHER INFORMATION CONTACT: Scott A. Brinks, Regulatory Drafting
and Policy Support Section, Diversion Control Division, Drug
Enforcement Administration; Telephone: (571) 776-3882.
SUPPLEMENTARY INFORMATION:
Posting of Public Comments
Please note that all comments received in response to this docket
are considered part of the public record. The Drug Enforcement
Administration (DEA) will make all comments available for public
inspection online at <a href="http://www.regulations.gov">http://www.regulations.gov</a>. Such information
includes personal or business identifiers (such as name, address, state
or Federal identifiers, etc.) voluntarily submitted by the commenter.
All information voluntarily submitted by the commenter, unless clearly
marked as Confidential Information in the method described below, will
be publicly posted. Comments may be submitted anonymously. The Freedom
of Information Act applies to all comments received.
Commenters submitting comments which include personal identifying
information (PII), confidential, or proprietary business information
that the commenter does not want made publicly available should submit
two copies of the comment. One copy must be marked ``CONTAINS
CONFIDENTIAL INFORMATION'' and should clearly identify all PII or
business information the commenter does not want to be made publicly
available, including any supplemental materials. DEA will review this
copy, including the claimed PII and confidential business information,
in its consideration of comments. The second copy should be marked ``TO
BE PUBLICLY POSTED'' and must have all claimed confidential PII and
business information already redacted. DEA will post only the redacted
comment on <a href="http://www.regulations.gov">http://www.regulations.gov</a> for public inspection.
For easy reference, an electronic copy of this document and a plain
language summary are available at <a href="http://www.regulations.gov">http://www.regulations.gov</a>.
Summary
On October 31, 2023, DEA published an advance notice of proposed
rulemaking (ANPRM) requesting stakeholder responses to ten questions
about methods and technology currently being utilized or developed to
render controlled substances non-retrievable.\1\ Since publication, DEA
received two requests from stakeholders for an extension of the comment
period due to timeliness difficulties preparing adequate comments to
the ANPRM during the holidays. One of those commenters, an association,
stated that its member companies have a significant interest in this
ANPRM, and requested an extension to allow them to provide timely and
informative comments.
---------------------------------------------------------------------------
\1\ 88 FR 74379 (Oct. 31, 2023).
---------------------------------------------------------------------------
After considering these requests for additional response time, DEA
is extending the comment period to allow stakeholders to prepare and
submit comments. This allows sufficient time for persons to evaluate
and consider all relevant information and respond accordingly.
Therefore, the comment period is extended to April 1, 2024. Electronic
comments must be submitted, and written comments must be postmarked, on
or before this date.
Signing Authority
This document of the Drug Enforcement Administration was signed on
December 28, 2023, by Administrator Anne Milgram. That document with
the original signature and date is maintained by DEA. For
administrative purposes only, and in compliance with requirements of
the Office of the Federal Register, the undersigned DEA Federal
Register Liaison Officer has been authorized to sign and submit the
document in electronic format for publication, as an official document
of DEA. This administrative process in no way alters the legal effect
of this document upon publication in the Federal Register.
Scott Brinks,
Federal Register Liaison Officer, Drug Enforcement Administration.
[FR Doc. 2023-28964 Filed 12-29-23; 11:15 am]
BILLING CODE 4410-09-P
</pre></body>
</html>Indexed from Federal Register on January 3, 2024.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.